Gladstone in the News
October 17, 2020
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts
COVID-19
Virology
Ott Lab
Gladstone in the News
October 14, 2020
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts
COVID-19
Cardiovascular Disease
Srivastava Lab
Gladstone in the News
October 8, 2020
The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts
COVID-19
Cardiovascular Disease
Center for HIV Cure Research
Greene Lab
Srivastava Lab
Gladstone in the News
October 5, 2020
San Francisco Chronicle—After the president was diagnosed with COVID-19, he received aggressive medical treatment. Gladstone Senior Investigator Warner Greene noted that the combination of drugs the president received has not been tested or proven effective, and that the dexamethasone he was given is a sign his illness might be more severe than it appears.
Gladstone Experts
COVID-19
Virology
Greene Lab
Gladstone in the News
October 1, 2020
Technology Network—Senior Investigator Bruce Conklin, MD, explains how SARS-CoV-2 damages heart cells and how heart cells grown in the lab could be used to screen for drugs against infection by the novel coronavirus.
Gladstone Experts
COVID-19
Cardiovascular Disease
Conklin Lab
Gladstone in the News
September 26, 2020
Life Science—The online science news hub Life Sciences highlights recent work from Senior Investigators Melanie Ott, MD, PhD, and Nevan Krogan, PhD, and their colleagues at BioHub and Synthego Corporation. The work describes the identification of host factors common to three coronaviruses including SARS-CoV-2, and could help bootstrap efforts to stem current and future coronavirus epidemics.
Gladstone Experts
COVID-19
Data Science and Biotechnology
Virology
Krogan Lab
Ott Lab
CRISPR/Gene Editing
Gladstone in the News
September 14, 2020
Wired—In an article about the potential dangers of strenuous exercise for people who have been infected with SARS-CoV-2, Senior Investigator Bruce Conklin, MD, is quoted for likening to "carnage" the damage the virus can inflict on heart cells. Conklin and Senior Investigator Todd McDevitt, PhD, recently reported their observations of cardiac cells from deceased COVID-19 patients or grown in the lab in BioRxiv.
Gladstone Experts
COVID-19
Cardiovascular Disease
Data Science and Biotechnology
Conklin Lab
McDevitt Lab
Gladstone in the News
September 10, 2020
The New Republic—Senior investigator Todd McDevitt, PhD, explains how his recent discovery that SARS-CoV-2 inflicts severe damage on heart cells could explain why some people experience symptoms of heart malfunction months after they recover from COVID-19. McDevitt stresses that COVID-19 is not just a respiratory disease, and could instead lead to permanent damage to various organs, even in young people.
Gladstone Experts
COVID-19
Cardiovascular Disease
McDevitt Lab
Gladstone in the News
September 10, 2020
Yahoo! News—Some individuals who survive the initial bout with COVID-19 experience heart damage weeks or months later. Gladstone Investigator Todd McDevitt explains how his recent research shows that SARS-CoV-2 can devastate heart muscle cells, which could have long-term consequences for heart function.
Gladstone Experts
COVID-19
Cardiovascular Disease
McDevitt Lab